Publications by authors named "Kevin D Courtney"

Claim this Profile
E
Extracranial Palliative Radiation Therapy for Renal Cell Carcinoma.
Young Suk Kwon, Eric Hsu, Maggie Stein, Alana Christie, Aurelie Garant, Kevin D Courtney

Adv Radiat Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.
Sumanta K Pal, Yohann Loriot, Andrea Necchi, Parminder Singh, Daniel Castellano, Kevin D Courtney

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial.
Jose De La Cerda, Laurence Belkoff, Kevin D Courtney, Elan Diamond, James D'Olimpio

Target Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial clinical experience with [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, Benjamin L Viglianti, Jeff M Michalski, Kevin D Courtney

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the radiologist in the prostate cancer multidisciplinary conference.
Daniel N Costa, Nghi Nguyen, Aurelie Garant, Xiaosong Meng, Kevin D Courtney

Abdom Radiol (NY)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the Prostate.
Haley Meyer, Rajitha Sunkara, Emily Rothmann, Amar Shah, Irbaz Riaz, Kevin Dale Courtney

Clin Genitourin Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial complex I promotes kidney cancer metastasis.
Divya Bezwada, Luigi Perelli, Nicholas P Lesner, Ling Cai, Bailey Brooks, Kevin D Courtney

Nature· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
Huma Q Rana, Jill E Stopfer, Michelle Weitz, Lindsay Kipnis, Diane R Koeller, Courtney Kokenakes, Kevin Dale Courtney

JCO Oncol Pract· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial metabolism in primary and metastatic human kidney cancers.
Divya Bezwada, Nicholas P Lesner, Bailey Brooks, Hieu S Vu, Zheng Wu, Kevin D Courtney

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma.
Shawn M Davidson, Daniel R Schmidt, Julia E Heyman, James P O'Brien, Amy C Liu, Kevin D Courtney

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer.
Xiaosong Meng, Murtaza Ahmed, Kevin D Courtney, Waddah Arafat, Ibrahim Ibrahim

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.
Mustafa Kinaan, Oksana Hamidi, Hanford Yau, Kevin D Courtney, Akin Eraslan

J Endocr Soc· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.
Kevin D Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG.
Louise Fets, Paul C Driscoll, Fiona Grimm, Aakriti Jain, Patrícia M Nunes, Kevin D Courtney

Nat Chem Biol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo.
Kevin D Courtney, Divya Bezwada, Tomoyuki Mashimo, Kumar Pichumani, Vamsidhara Vemireddy

Cell Metab· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG.
Louise Fets, Paul C Driscoll, Fiona Grimm, Aakriti Jain, Patrícia M Nunes, Kevin D Courtney

Nat Chem Biol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.
Kevin D Courtney, Jeffrey R Infante, Elaine T Lam, Robert A Figlin, Brian I Rini

J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.
Kevin D Courtney, Judith B Manola, Aymen A Elfiky, Robert Ross, William K Oh

Clin Genitourin Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
Mari Nakabayashi, Lilian Werner, Kevin D Courtney, Geoffrey Buckle, William K Oh

BJU Int· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
Dimitrios Anastasiou, Yimin Yu, William J Israelsen, Jian-Kang Jiang, Matthew B Boxer, Kevin D Courtney

Nat Chem Biol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer.
Kevin D Courtney, Mary-Ellen Taplin

Curr Opin Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on novel therapies for metastatic renal cell carcinoma.
Kevin D Courtney, Toni K Choueiri

Ther Adv Med Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PI3K pathway as drug target in human cancer.
Kevin D Courtney, Ryan B Corcoran, Jeffrey A Engelman

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing recent advances in metastatic renal cell carcinoma.
Kevin D Courtney, Toni K Choueiri

Curr Oncol Rep· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K enters beta-testing.
Adam J Shaywitz, Kevin D Courtney, Akash Patnaik, Lewis C Cantley

Cell Metab· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis